Gabelli Funds’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Gabelli Funds’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-39,400	Closed	-$5.18M	–	1455
2020 Q4	$5.18M	Buy	+39,400	New	+$3.48M	0.04%	467

Gabelli Funds's EIDX Position: Q1 2021 in Review

Gabelli Funds sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 39,400 shares — an estimated $5.18M sold.

Gabelli Funds first reported a position in EIDX in Q4 2020 and held it in 1 quarter. The position peaked at $5.18M in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

Gabelli Funds reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Gabelli Funds sold 39,400 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $5.18M.
Gabelli Funds first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Gabelli Funds's Eidos Therapeutics, Inc. Common Stock position peaked at $5.18M in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Gabelli Funds's 13F filing for Q1 2021, filed 14 May 2021.